Gene · 7033
Papers3,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. | J Pers Med | 2022 | 36556227 | PubTator, text mining | PubMed |
| Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer. | Curr Issues Mol Biol | 2022 | 36547059 | PubTator, text mining | PubMed |
| Effects of short-chain fatty acids on intestinal function in an enteroid model of hypoxia. | Front Physiol | 2022 | 36545280 | PubTator, text mining | PubMed |
| Neoadjuvant VS adjuvant chemotherapy in patients with locally advanced breast cancer; a retrospective cohort study. | Ann Med Surg (Lond) | 2022 | 36536751 | PubTator, text mining | PubMed |
| Epidemiology and renal injury following 2-methyl-4-chlorophenoxyacetic acid (MCPA) poisoning. | Sci Rep | 2022 | 36535986 | PubTator, text mining | PubMed |
| New insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines. | Front Microbiol | 2022 | 36519164 | PubTator, text mining | PubMed |
| Biomarkers of gut injury in neonates - where are we in predicting necrotising enterocolitis? | Front Pediatr | 2022 | 36518779 | PubTator, text mining | PubMed |
| IFNγ-dependent silencing of TFF1 during Helicobacter pylori infection. | Open Biol | 2022 | 36514982 | PubTator, text mining | PubMed |
| Different Molecular Forms of TFF3 in the Human Respiratory Tract: Heterodimerization with IgG Fc Binding Protein (FCGBP) and Proteolytic Cleavage in Bronchial Secretions. | Int J Mol Sci | 2022 | 36499686 | PubTator, text mining | PubMed |
| Polyphenols from foxtail millet bran ameliorate DSS-induced colitis by remodeling gut microbiome. | Front Nutr | 2022 | 36479296 | PubTator, text mining | PubMed |
| Biological implications and clinical potential of invasion and migration related miRNAs in glioma. | Front Integr Neurosci | 2022 | 36479040 | PubTator, text mining | PubMed |
| Screening and validation of lymph node metastasis risk-factor genes in papillary thyroid carcinoma. | Front Endocrinol (Lausanne) | 2022 | 36465624 | PubTator, text mining | PubMed |
| The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines. | Sci Rep | 2022 | 36463254 | PubTator, text mining | PubMed |
| Comparison of cell type distribution between single-cell and single-nucleus RNA sequencing: enrichment of adherent cell types in single-nucleus RNA sequencing. | Exp Mol Med | 2022 | 36460793 | PubTator, text mining | PubMed |
| Generation and multiomic profiling of a TP53/CDKN2A double-knockout gastroesophageal junction organoid model. | Sci Transl Med | 2022 | 36449602 | PubTator, text mining | PubMed |
| Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer. | NPJ Breast Cancer | 2022 | 36446866 | PubTator, text mining | PubMed |
| A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. | Front Oncol | 2022 | 36439479 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer. | Cancers (Basel) | 2022 | 36428707 | PubTator, text mining | PubMed |
| Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy. | Cancers (Basel) | 2022 | 36428623 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7033/papers?page=26